The latest SOCT 21.5.0 software update for the Revo optical coherence tomography (OCT) device is a major advancement for diabetic eye care with its new widefield fundus imaging capability.
By stitching up to nine internal fixation positions into a seamless mosaic, clinicians gain a significantly broader view of the retina, enabling clearer assessment of peripheral pathology often missed in standard imaging. This expanded field enhances the detection of early diabetic changes, supports more accurate grading, and improves long-term monitoring.
Complemented by upgraded EyeTracking for more stable acquisition and new fundus review filters, the update delivers sharper, more reliable images across diverse examination conditions. Together, these enhancements elevate the Revo FC into a more powerful, comprehensive tool for managing diabetic eye disease.
Visit: Optopol.au or contact sales@optopol.au
